NEWS

News Articles

LanzaJet Takes Off: Innovative Sustainable Fuel Technology and Investment Structure to Accelerate Commercialization, Regional Job Growth, and Carbon Reduction

June 4, 2020

LanzaTech, a leading biotech company and carbon recycler, has successfully launched LanzaJet, Inc., a new company that will produce sustainable aviation fuel (SAF) for a sector requiring climate friendly fuel options as it starts to recover from the impacts of COVID-19. With its approach to commercialization of SAF, LanzaJet is creating regional jobs while enabling…

Read More

HHS Provides an Additional $250 Million to Help U.S. Health Care Systems Respond to COVID-19

June 2, 2020

The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) is providing an additional $250 million to aid U.S. health care systems treating patients and responding to the COVID-19 pandemic. As authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, HHS has now provided a total of…

Read More

BIO and CSBA Letter to Congress to Support One Health and Advance Animal Biotech

June 2, 2020

The Biotechnology Innovation Organization (BIO), along with the 27 members of the Council of State Bioscience Associations (CSBA), urge Congress to support the Advancing Emergency Preparedness Through One Health Act and advance legislation directing the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop a Memorandum of Understanding (MOU) to…

Read More

Steven Damon Appointed Chief Executive Officer of Micron Biomedical, a Novel Vaccine and Therapeutic Technology Company

June 1, 2020

Micron Biomedical, Inc., an Atlanta based biopharmaceutical company, has appointed industry veteran, Steven Damon, as the company CEO. Mr. Damon will lead Micron on a path to rapid development and commercialization of Micron’s proprietary dissolvable, microneedle-based technology, a novel technology designed for simple, safe and effective self-dosing of vaccines and therapeutics. “The time is right…

Read More

A New Program to Support Continued Biotechnology Innovation

June 1, 2020

At Pfizer, our Purpose – breakthroughs that change patients’ lives – propels us to find innovative solutions for patients with high unmet medical needs in various therapeutic areas. We share this goal with many innovative companies within the biotech community and we have a long history of collaboration with them and many others across the…

Read More

Quest Diagnostics’ COVID-19 test kit gets FDA nod for emergency use

May 28, 2020

Quest Diagnostics said on Thursday it received emergency use authorization (EUA) for its self-collection COVID-19 test kit from the U.S. Food and Drug Administration, sending its shares up 3%.  The company expects to have more than half a million kits available by end of June and more as required later.  Several medical device makers and…

Read More